Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (241-250 of 287) with videos related to

Pageof 29
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force ReportDaniel C Malone, Scott D Ramsey, Donald L Patrick, et al.
The Patient|September 28, 2022
Constructing Health State Descriptions for Low-Risk Thyroid Cancer: Stakeholder Engagement and Formative Qualitative ResearchErin G Roth, Justin Kim, Julia F Slejko, et al.
BMJ Open|October 13, 2019
Which orthopaedic trauma patients are likely to refuse to participate in a clinical trial? A latent class analysisNathan N O'Hara, Yasmin Degani, Debra Marvel, et al.
JCO Clinical Cancer Informatics|January 18, 2019
An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics ToolEberechukwu Onukwugha, Jinani Jayasekera, James Gardner, et al.
BMJ Open|August 13, 2017
Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experimentBryce E Haac, Nathan N O'Hara, C Daniel Mullins, et al.
Clinical Trials (London, England)|August 29, 2013
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT studyJason T Connor, Bryan R Luce, Kristine R Broglio, et al.
BMC Medicine|December 6, 2021
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trialsYoon Duk Hong, Jeroen P Jansen, John Guerino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2016
Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression StudyGail B Rattinger, Elizabeth B Fauth, Stephanie Behrens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2009
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part IJoel W Hay, Jim Smeeding, Norman V Carroll, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|October 14, 2023
Ability of Caprini and Padua risk-assessment models to predict venous thromboembolism in a nationwide Veterans Affairs studyHilary Hayssen, Shalini Sahoo, Phuong Nguyen, et al.
Pageof 29

Showing results (241-250 of 287) with videos related to

Sort By:
Pageof 29
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force ReportDaniel C Malone, Scott D Ramsey, Donald L Patrick, et al.
The Patient|September 28, 2022
Constructing Health State Descriptions for Low-Risk Thyroid Cancer: Stakeholder Engagement and Formative Qualitative ResearchErin G Roth, Justin Kim, Julia F Slejko, et al.
BMJ Open|October 13, 2019
Which orthopaedic trauma patients are likely to refuse to participate in a clinical trial? A latent class analysisNathan N O'Hara, Yasmin Degani, Debra Marvel, et al.
JCO Clinical Cancer Informatics|January 18, 2019
An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics ToolEberechukwu Onukwugha, Jinani Jayasekera, James Gardner, et al.
BMJ Open|August 13, 2017
Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experimentBryce E Haac, Nathan N O'Hara, C Daniel Mullins, et al.
Clinical Trials (London, England)|August 29, 2013
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT studyJason T Connor, Bryan R Luce, Kristine R Broglio, et al.
BMC Medicine|December 6, 2021
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trialsYoon Duk Hong, Jeroen P Jansen, John Guerino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2016
Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression StudyGail B Rattinger, Elizabeth B Fauth, Stephanie Behrens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2009
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part IJoel W Hay, Jim Smeeding, Norman V Carroll, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|October 14, 2023
Ability of Caprini and Padua risk-assessment models to predict venous thromboembolism in a nationwide Veterans Affairs studyHilary Hayssen, Shalini Sahoo, Phuong Nguyen, et al.
Pageof 29